Vor Biopharma Prices IPO at $18 Per Share
07:15 AM EST, 02/05/2021 (MT Newswires) -- Vor Biopharma on Friday priced its initial public offering of 9,828,017 shares of its common stock at $18 per share for gross proceeds of approximately $176.9 million.
Underwriters have been granted a 30-day option to purchase up to an additional 1,474,202 common shares.
The shares are expected to begin trading on the Nasdaq Global Market this Friday under the ticker symbol, "VOR."
The offering is expected to close on Feb. 9.